Chromocell Therapeutics
$13.5
5
+$0.9+7.14% Tuesday 20:00
Statistics
Day High
1.41
Day Low
1.23
52W High
54.29
52W Low
1.23
Volume
193,120
Avg. Volume
129,150
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
3DecExpected
Expected EPS
-0.55
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-7.96MNet Income
Analyst Ratings
$55.00Average Price Target
The highest estimate is 62.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CHRO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Channel Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Show more...
CEO
Mr. Francis Knuettel II, M.B.A.
Employees
4
Country
US
ISIN
US1711261057
Listings
0 Comments
Share your thoughts
FAQ
What is Chromocell Therapeutics stock price today?▼
The current price of CHRO is $13.5 USD — it has increased by +7.14% in the past 24 hours. Watch Chromocell Therapeutics stock price performance more closely on the chart.
What is Chromocell Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Chromocell Therapeutics stocks are traded under the ticker CHRO.
Is Chromocell Therapeutics stock price growing?▼
CHRO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Chromocell Therapeutics has showed a +0% increase.
What is Chromocell Therapeutics revenue for the last year?▼
Chromocell Therapeutics revenue for the last year amounts to 0 USD.
What is Chromocell Therapeutics net income for the last year?▼
CHRO net income for the last year is -7.96M USD.
How many employees does Chromocell Therapeutics have?▼
As of April 01, 2026, the company has 4 employees.
In which sector is Chromocell Therapeutics located?▼
Chromocell Therapeutics operates in the Health Care sector.
When did Chromocell Therapeutics complete a stock split?▼
The last stock split for Chromocell Therapeutics was on July 02, 2025 with a ratio of 1:10.
Where is Chromocell Therapeutics headquartered?▼
Chromocell Therapeutics is headquartered in Freehold, US.